Dyslipidemia in pregnancy

Cardiol Clin. 2015 May;33(2):209-15. doi: 10.1016/j.ccl.2015.01.002.

Abstract

"Recent studies have revealed evidence that poorly controlled cholesterol, triglycerides, and their metabolites during pregnancy may be associated with cardiometabolic dysfunction and have significant detrimental fetal and maternal vascular consequences. Cardiometabolic dysfunction during pregnancy may not only contribute to long-term effects of the mother and child's vascular health but also potentially create cardiovascular risk for generational offspring. This article provides updates on this rapidly expanding and multifaceted topic and reviews new insight regarding why recognition of this disordered maternal cholesterol and triglyceride metabolism is likely to have long-term effect on the increasing atherosclerotic burden of the burgeoning population."

Keywords: Dyslipidemia; Fetal metabolism; Hyperlipidemia; Metabolic syndrome; Pregnancy.

Publication types

  • Review

MeSH terms

  • Disease Management*
  • Dyslipidemias* / blood
  • Dyslipidemias* / epidemiology
  • Dyslipidemias* / prevention & control
  • Female
  • Fetus / metabolism*
  • Humans
  • Lipids / blood*
  • Pregnancy
  • Pregnancy Complications, Cardiovascular*
  • Risk Factors

Substances

  • Lipids